Table 5.
Outcome in 408 Adolescent Inpatients with or without Aggressive Episodes Requiring an Intervention (AERI+ [n=116] vs. AERI− [n=292])
| Total | AERI+ | AERI− | p value | |
|---|---|---|---|---|
| GAF at discharge (mean, SD) | 50.6±9.8 | 48.9±9.9 | 51.2±9.8 | 0.0407 |
| Change in GAF (admission to discharge; mean, SD) | 18.6±11.1 | 18.1±11.0 | 18.7±11.1 | 0.6167 |
| Median length of stay (days; 25th, 75th percentile) | 13.0 (8; 34.75) | 49.5 (17.3; 96.5) | 10.0 (7.0; 18.0) | <0.0001 |
| Perspective at discharge (n, %) | ||||
| Outpatient care | 269 (67.3) | 53 (46.5) | 216 (75.5) | <0.0001 |
| Day hospital | 62 (15.5) | 23 (20.2) | 39 (13.6) | 0.1028 |
| Residential treatment facility | 42 (10.5) | 26 (22.8) | 16 (5.6) | <0.0001 |
| Inpatient facility | 27 (6.8) | 12 (10.5) | 15 (5.2) | 0.0574 |
| Pharmacological treatment at discharge | ||||
| Median # of medications (25th, 75th percentile) | 2 (1; 2) | 2 (2; 3) | 1 (1; 2) | <0.0001 |
| Change # of medications, baseline to discharge (±SD) | 0.50±1.1 | 0.72±1.2 | 0.41±0.95 | 0.0079 |
| Antipsychotics (n, %) | 200 (49.0) | 83 (71.6) | 117 (40.1) | <0.0001 |
| First-generation antipsychotics (n, %) | 12 (2.9) | 7 (6.0) | 5 (1.7) | 0.0198 |
| Second-generation antipsychotics (n, %) | 190 (46.6) | 77 (66.4) | 113 (38.7) | <0.0001 |
| Antidepressants (n, %) | 190 (46.6) | 44 (37.9) | 146 (50.0) | 0.0275 |
| Mood stabilizers (n, %) | 189 (46.3) | 78 (67.2) | 111 (38.0) | <0.0001 |
| Lithium (n, %) | 71 (17.4) | 29 (25.0) | 42 (14.4) | 0.01 |
| Anxiolytics/Hypnotics (n, %) | 42 (10.3) | 13 (11.2) | 29 (9.9) | 0.7022 |
| Stimulants (n, %) | 37 (9.1) | 17 (14.7) | 20 (6.9) | 0.0133 |
| Anticholinergics (n, %) | 19 (4.7) | 10 (8.6) | 9 (3.1) | 0.02 |
| Alpha 2 agonists (n, %) | 9 (2.2) | 4 (3.5) | 5 (1.7) | 0.2815 |
GAF, Global Assessment of Functioning.